Quick Answer
Sonoma Pharmaceuticals, Inc. reported Stockholders Equity of $4.41 million for fiscal year 2025.
Sonoma Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.41M | -28.1% |
| 2024 | $6.14M | -23.1% |
| 2023 | $7.98M | -8.3% |
| 2022 | $8.70M | +62.2% |
| 2021 | $5.36M | -4.6% |
| 2020 | $5.62M | -27.6% |
| 2019 | $7.77M | -49.3% |
| 2018 | $15.33M | -28.5% |
| 2017 | $21.43M | +111.4% |
| 2016 | $10.14M | -15.9% |
| 2015 | $12.05M | -0.1% |
| 2014 | $12.06M | +195.6% |
| 2013 | $4.08M | +570.2% |
| 2012 | -$868.0K | -151.0% |
| 2011 | $1.70M | -75.9% |
| 2010 | $7.04M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $3.43M | -29.5% | -9.4% |
| September 30, 2025 | $3.79M | -29.2% | -6.6% |
| June 30, 2025 | $4.06M | -18.5% | -8.0% |
| March 31, 2025 | $4.41M | -28.1% | -9.4% |
| December 31, 2024 | $4.87M | -27.2% | -9.0% |
| September 30, 2024 | $5.35M | -5.7% | +7.6% |
| June 30, 2024 | $4.97M | -31.3% | -18.9% |
| March 31, 2024 | $6.14M | -23.1% | -8.3% |
- Sonoma Pharmaceuticals, Inc. showed a decrease of -28.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, Sonoma Pharmaceuticals, Inc.’s stockholders equity has declined by 37.4% (from $7.04 million to $4.41 million).
- The most recent figure is from Sonoma Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: